Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA’s Absence Raises Concerns About International Standards Development
Feb 06 2025
•
By
Elizabeth Orr
US companies could have trouble selling products overseas if standards are not aligned.
(metamorworks/Shutterstock)
More from R&D
More from Legislation